About Clinical Endpoints
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Clinical Endpoints
During the past decade, Clinical Endpoints conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Endpoints"
#1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Clinical Endpoints
According to Clinical.Site data, the most researched conditions in "Clinical Endpoints" are
"Alzheimer Disease" (3 trials) and "Alzheimer's Disease With Vascular Pathology" (1 trials). Many other conditions were trialed in "Clinical Endpoints" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Endpoints
Most popular intervention types in "Clinical Endpoints" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "ACU193" (1 trials), "CY6463" (1 trials), "NE3107" (1 trials) and "Simufilam" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Endpoints
The vast majority of trials in "Clinical Endpoints" are
4 trials for "All" genders.
Clinical Trials Status at Clinical Endpoints
Currently, there are NaN active trials in "Clinical Endpoints".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Clinical Endpoints,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Endpoints, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".